Top Markets
Coin of the day
Brickell Biotech, Inc. Brickell Biotech, Inc.

Brickell Biotech, Inc.

BBI
Rank in Stocks #40377
Brickell Biotech, Inc. is a pharmaceutical company currently in the clinical... Brickell Biotech, Inc. is a pharmaceutical company currently in the clinical development phase, dedicated to creating prescription medicines for various debilitating conditions, including autoimmune and inflammatory disorders, primarily within the United States. Its product pipeline includes sofpironium bromide, which has successfully finished Phase III clinical trials for treating excessive underarm sweating (primary axillary hyperhidrosis). Other notable candidates are BBI-02, an oral DYRK1A inhibitor targeting autoimmune and inflammatory diseases, and BBI-10, a covalent stimulator of interferon genes (STING) inhibitor, being explored for autoinflammatory and rare genetic illnesses. The company is also advancing next-generation kinase inhibitors. Brickell Biotech collaborates with several partners, such as Carna Biosciences, Inc., Voronoi Inc., Bodor Laboratories, Inc. and Dr. Nicholas S. Bodor, and AnGes, Inc. Established in 2009, its main office is located in Boulder, Colorado.
Share Price
$2.35
Last synced: 2022-09-07
Market Cap
$162.94K
Change (1 day)
2.17%
Change (1 year)
0.00%
Country
US
Trade Brickell Biotech, Inc. (BBI)

Category

Price of BBI with the market cap of B
Brickell Biotech, Inc. Brickell Biotech, Inc.
BBI
$2.35
Market Capitalization of Brickell Biotech, Inc.(BBI)
Market Cap: $162.94K
As of August 2026 Brickell Biotech, Inc. has a market cap of $162.94K. This makes Brickell Biotech, Inc. the world's 40377th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.
Market cap history of Brickell Biotech, Inc. from 2019 to 2026
BBI compared with Top 5 Most Popular stocks
Price of BBI Asset B Mkt. of B Results
Brickell Biotech, Inc. Brickell Biotech, Inc.
$78,884,530 $162.94K
$5.470T +3,356,788,414.27%
Brickell Biotech, Inc. Brickell Biotech, Inc.
$64,426,434 $162.94K
$4.467T +2,741,550,267.91%
Brickell Biotech, Inc. Brickell Biotech, Inc.
$60,205,180 $162.94K
$4.174T +2,561,922,456.83%
Brickell Biotech, Inc. Brickell Biotech, Inc.
$53,364,447 $162.94K
$3.700T +2,270,827,439.47%
Brickell Biotech, Inc. Brickell Biotech, Inc.
$41,166,821 $162.94K
$2.854T +1,751,779,516.19%